Skip to content
Clinical Trials – home
Therapeutic area

Psychiatric disorders – page 33

  • 546 clinical trials
  • 252 recruiting
  • 147 conditions
  • 26 countries

Conditions in this area

147 conditions with trials, the busiest first

Clinical trials in Psychiatric disorders

546 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

546 clinical trials

Study on Oxytocin and Sodium Chloride for Preventing Drug Relapse in Individuals with Substance Use Disorder

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · Healthy volunteers
  • Substances:Oxytocin
  • Sponsor:Fondazione Santa Lucia

Title: Study of LP352 (bexicaserin) oral solution versus placebo for treating seizures in children and adults with Developmental and Epileptic Encephalopathies

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Longboard Pharmaceuticals Inc.

Anxiety

Not recruiting

Title: Evaluation of nasal remimazolam and lidocaine for sedation and anxiety in adults: Testing comfort and effectiveness of nasal spray delivery

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Remimazolam
  • Sponsor:Stichting Radboud University Medical Center

Anxiety

Not recruiting

Study on the Effects of Yohimbine and Hydrocortisone on Stress and Moral Decisions in Military Personnel

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Hydrocortisone
  • Sponsor:Universitair Medisch Centrum Utrecht

Drug use disorder

Not recruiting

Study on the Effects of Naloxegol and Codeine on Opioid-Induced Constipation in Healthy Volunteers

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
  • Substances:Bisacodyl
  • Sponsor:UZ Leuven

Alcohol use disorder

Not recruiting

Study on Oxytocin for Improving Behavior in Young Adults with Alcohol Use Disorder

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · Healthy volunteers
  • Substances:Oxytocin
  • Sponsor:Karolinska Institutet

Study on the Safety and Effects of Plasma Transfusion from Exercise-Trained Donors in Patients with Early Alzheimer's Disease Using Human Plasma Protein and Saline

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Human Plasma Protein
  • Sponsor:Norwegian University Of Science And Technolology

Depression

Not recruiting

Psilocybin Therapy for Hospitalized Patients with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
  • Sponsor:Universitair Ziekenhuis Gent

Anhedonia

Not recruiting

Study on Pramipexole for Reducing Anhedonia in Patients with Major Depression

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pramipexole
  • Sponsor:Region Skane

Perinatal depression

Not recruiting

Study on Using Estradiol to Prevent Postpartum Depression in Women with a History of the Condition

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Estradiol
  • Sponsor:Region Hovedstaden

Cognitive disorder

Not recruiting

Study on the Effects of Donepezil on Cognitive and Motor Functions in Elderly Patients with Neurological Disorders

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Donepezil Hydrochloride
  • Sponsor:Carl Von Ossietzky Universitaet Oldenburg

Anorexia nervosa

Not recruiting

Study on the Role of Serotonin and Sodium Chloride in Brain Circuits for Food Avoidance in Patients with Anorexia Nervosa

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:3-AMINO-4-[2-[[METHYL((111C)METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE
  • Sponsor:Centre Hospitalier Universitaire De Saint Etienne

Substances studied in this area

The therapies tested most often in Psychiatric disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.